| TITLE |
Broadcast Date |
| August Washington Update |
August 5, 2022 |
| Maximizing Medicaid: How Provider Status Intersects with Medicaid Coverage
|
July 7, 2022 |
| Advocacy Roundtable Discussion |
June 30, 2022 |
Mainstreaming Addiction Treatment Act and What it Means For Patients
|
June 1, 2022 |
| A Discussion on the Introduction of the Equitable Community Access to Pharmacist Services Act (H.R. 7213) |
May 3, 2022 |
| CDC’s Draft Clinical Practice Guideline for Prescribing Opioids: What It Means for Practice |
April 5, 2022 |
| CMS Takes on DIR Fees |
March 1, 2022 |
| Connecting the Dots between Diversity, Equality, and Inclusion and Advocacy |
February 18, 2022 |
| ASHP’s New Drug Supply Chain Recommendations |
January 4, 2022 |
| ASHP’s Statement on Pharmacist Payment for COVID-19 Oral Antivirals Explained |
December 15, 2021 |
| FDA’s New Draft Hospital/Health-System Compounding Guidance: What Does It Mean for Practice? |
November 10, 2021 |
| A Look at ASHP Federal Legislative Priorities from 2021’s Virtual Legislative Week |
October 5, 2021 |
| Efforts to Expand Pharmacists’ Authority to Independently Order and Administer Therapeutics for Treatment and Prevention of COVID-19 |
September 10, 2021 |
| Advocating for Impact: 2021 State Provider Status Legislation Midyear Review |
August 3, 2021 |
| Advocating for Impact: Pharmacy and Medically Underserved Areas Enhancement Act: An Insider’s Perspective |
June 25, 2021 |
| Advocating for Impact: Pandemic and Beyond - Policy and Advocacy Matters |
June 14, 2021 |
| Advocating for Impact: Advancing Pharmacist Recognition |
June 1, 2021 |
| A Discussion on the Reintroduction of the Pharmacy and Medically Underserved Areas Enhancement Act |
May 13, 2021 |
| Advocating for Impact: A Court Win for Pharmacy Residency Programs |
April 23, 2021 |
| Advocating for Impact: 2021 Federal Advocacy Priorities |
March 16, 2021 |
| Advocating for Impact: 340B Litigation Update |
March 2, 2021 |
| Advocating for Impact: White Bagging - Implications for Patient Safety and Access to Care |
February 3, 2021 |
| PBMs on Trial: The Practical Implications of SCOTUS’s Rutledge v. PCMA Decision |
December 18, 2020 |
| Advocating for Impact: How The Election Results Impact Your Practice |
December 1, 2021 |
| Advocating for Impact: Track and Trace - A DSCSA Refresher |
November 5, 2020 |
| Advocating for Impact: 340B Under Attack |
|
| The White House Just Released Several New Policies: Here’s how they’re likely to play out |
|
| Pharmacy Before The Supreme Court: Listen to ASHP’s analysis of Supreme Court arguments in Rutledge vs PCMA |
|
| Advocating for Impact: USPS Mail Order Medication Difficulties |
|
| Student Perspectives: SSHPs and Advocacy |
|
| Advocating for Impact: Deciphering CMS’s Telehealth Changes |
|
| Advocating for Impact: Demystifying Lobbying and Advocacy on behalf of Pharmacists |
|
| 340B Health and Advocacy |
|
| Advancing Scope of Practice: New Mexico |
|
| CMS and Scope of Practice – Decoding CMS’s Deregulatory Efforts |
|
| Drug Pricing: A Conversation with Tom Kraus and Doug Huynh |
|
| Drug Shortages: A Conversation with Erin R. Fox, Pharm.D., BCPS, FASHP |
|
